Caris Life Sciences, Inc. (CAI) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Caris Life Sciences, Inc., with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | -83.86x | -25.30x | -20.89x | -22.24x | 18.12x | 16.26x |
| P/B Ratio | 78.14x | -2.85x | -3.32x | -4.19x | 0.72x | 0.73x |
| P/S Ratio | 55.55x | 17.30x | 23.29x | 27.60x | 1.71x | 1.21x |
| Profitability | ||||||
| Gross Margin | 66.4% | 43.4% | 29.2% | 31.0% | 62.6% | 48.1% |
| Operating Margin | 5.6% | -62.4% | -104.4% | -122.2% | 47.3% | 31.3% |
| Net Margin | -66.2% | -68.4% | -111.5% | -124.1% | 9.4% | 7.4% |
| EBITDA Margin | 1.4% | -44.4% | -85.2% | -95.1% | 86.5% | 59.6% |
| Liquidity | ||||||
| Current Ratio | 7.85x | 1.30x | 2.55x | 3.77x | 0.67x | 1.74x |
| Quick Ratio | 7.85x | 1.06x | 2.04x | 3.43x | 0.67x | 1.74x |
| Leverage | ||||||
| Debt/Equity | 0.66x | -0.17x | -0.10x | -0.16x | 2.49x | 3.03x |
YoY = year-over-year change. Source: FMP..